R. Dubois (London, United Kingdom), B. Balbi (Gussago, Italy)
Microarrays reveal coordinated expression of ADAMs family of genes in an in vitro model of pulmonary fibrosis
D. T. Keating, P. P. Doran, A. Patricelli, J. J. Egan (Dublin, Ireland)
|   |
Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis
M. Vasakova, I. Striz, A. Slavcev, S. Jandova, J. Sulc (Prague, Czech Republic)
| |
Expression of insulin-growth factor-I (IGF-I) in alveolar lymphocytes (AL) in interstitial lung diseases (ILD). Potential functions of AL-derived IGF
P. Kopinski, J. Soja, A. Szlubowski, M. Plato, J. Szczeklik, K. Sladek (Bydgoszcz, Krakow, Poland)
| |
Proteomic analysis of BALf in systemic sclerosis patients (SSp) with or without pulmonary fibrosis (ILD)
A. M. Bardoni, R. Salvini, I. Passadore, C. Di Poto, C. Montecucco, E. Pozzi, F. Meloni, A. M. Fietta (Pavia, Italy)
| |
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
M. Ebina, A. Ishizaka, Y. Kimura, R. Tazawa, T. Nukiwa (Sendai, Tokyo, Japan)
| |
Auto-antibody subsets and extent of pulmonary fibrosis in systemic sclerosis (SSc)
R. K. Hoyles, C. P. Denton, A. U. Wells (London, United Kingdom)
| |
Bronchoalveolar lavage fluid analysis is essential for early diagnosis of respiratory manifestation in Niemann-Pick disease
N. Guillemot, T. Billette, A. Clement, M. T. Vanier, E. Ralph, C. Troadec (Paris, Lyon, France)
| |
Pneumothorax after air travel in pulmonary lymphangioleiomyomatosis (LAM): a European survey of 145 patients
R. Lazor, M. Gonsalves, L. Falconer, E. Miano, S. Geilling, S. Johnson, A. E. Tattersfield, J. Cordier, and Eurolam (Bern, Switzerland; , ; Nottingham, United Kingdom; Lyon, France)
| |